Crescent Capital BDC Q3: NAV Falls to $17.72 From $19.10, Non-Accruals Rise to 12 Companies
CCAP is trading near its 52-week low of $8.395 (10% above the low).
Summary
Crescent Capital BDC's Q3 2026 report shows NAV per share down to $17.72 from $19.10 at year-end, lower net investment income, and non-accruals up to twelve portfolio companies, partly offset by reduced management and incentive fees.
Key Events · Earnings and Guidance · CCAP
-
NAV Per Share Falls to $17.72
Net asset value per share declined to $17.72 at September 30, 2026 from $19.10 at December 31, 2025, while total net assets fell to $652,932 thousand from $706,038 thousand.
-
Nine-Month Net Result Turns Negative
For the nine months ended September 30, 2026, the net decrease in net assets resulting from operations was $8,646 thousand, versus a $26,019 thousand increase in the prior-year period.
-
Net Investment Income Drops
Net investment income fell to $42,281 thousand from $50,437 thousand a year earlier, as total investment income declined to $111,121 thousand from $126,473 thousand.
-
Non-Accruals Rise to Twelve Companies
Twelve portfolio companies were on non-accrual status at September 30, 2026, representing 4.7% of total debt investments at cost and 2.2% at fair value, up from eleven at December 31, 2025.
Analysis · CCAP · Unknown
The headline is NAV erosion: net asset value per share dropped to $17.72 from $19.10 at year-end 2025, and the nine-month net decrease in net assets from operations was $8,646 thousand versus a $26,019 thousand increase a year earlier. Net investment income fell to $42,281 thousand from $50,437 thousand as total investment income declined to $111,121 thousand from $126,473 thousand. Non-accrual names rose to twelve portfolio companies, 4.7% of debt investments at cost. The one offset is cost: the base management fee was cut to 1.00% from 1.25% and the income incentive fee to 15.0% from 17.5% effective April 1, 2026, which trims the expense drag on future earnings.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CCAP was trading at $9.24 on NASDAQ in the Unknown sector, with a market capitalization of approximately $340.5M. The 52-week trading range was $8.40 to $15.18. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.